|Göteborgs universitets publikationer
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Författare och institution:
Frida Abel (Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik); Daniel Dalevi (-); Maria Nethander (Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik); Rebecka Jörnsten (-); Katleen De Preter (-); Joëlle Vermuelen (-); Raymond Stallings (-); Per Kogner (-); John Maris (-); Staffan Nilsson (Institutionen för matematiska vetenskaper, matematisk statistik, Chalmers/GU)
Cancer Cell International, 11 ( 9 )
Artikel, refereegranskad vetenskaplig
Fulltextlänk (lokalt arkiv):
Abstract Background There are currently three postulated genomic subtypes of the childhood tumour neuroblastoma (NB); Type 1, Type 2A, and Type 2B. The most aggressive forms of NB are characterized by amplification of the oncogene MYCN (MNA) and low expression of the favourable marker NTRK1. Recently, mutations or high expression of the familial predisposition gene Anaplastic Lymphoma Kinase (ALK) was associated to unfavourable biology of sporadic NB. Also, various other genes have been linked to NB pathogenesis. Results The present study explores subgroup discrimination by gene expression profiling using three published microarray studies on NB (47 samples). Four distinct clusters were identified by Principal Components Analysis (PCA) in two separate data sets, which could be verified by an unsupervised hierarchical clustering in a third independent data set (101 NB samples) using a set of 74 discriminative genes. The expression signature of six NB-associated genes ALK, BIRC5, CCND1, MYCN, NTRK1, and PHOX2B, significantly discriminated the four clusters (p < 0.05, one-way ANOVA test). PCA clusters p1, p2, and p3 were found to correspond well to the postulated subtypes 1, 2A, and 2B, respectively. Remarkably, a fourth novel cluster was detected in all three independent data sets. This cluster comprised mainly 11q-deleted MNA-negative tumours with low expression of ALK, BIRC5, and PHOX2B, and was significantly associated with higher tumour stage, poor outcome and poor survival compared to the Type 1-corresponding favourable group (INSS stage 4 and/or dead of disease, p < 0.05, Fisher's exact test). Conclusions Based on expression profiling we have identified four molecular subgroups of neuroblastoma, which can be distinguished by a 6-gene signature. The fourth subgroup has not been described elsewhere, and efforts are currently made to further investigate this group's specific characteristics.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
MEDICIN OCH HÄLSOVETENSKAP
EXPRESSION-BASED CLASSIFICATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENE; ACTIVATING MUTATIONS; ONCOLOGY GROUP; MESSENGER-RNA; COPY NUMBER; ALK KINASE; AMPLIFICATION; PROGRESSION
© 2011 Abel et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.